Dr. John Leonard joins 3T board of directors

Immunotherapy company 3T Biosciences has named John Leonard, MD, to its board of directors. 

Currently, Dr. Leonard serves as president and CEO of Intellia Therapeutics. Prior to Intellia, Dr. Leonard was the chief scientific officer and global vice president of research and development at AbbVie, according to an Oct. 25 3T news release. 

Dr. Leonard has worked on HIV inhibitors Norvir and Kaletra as well as the  top-selling arthritis pain reliever Humira. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast

Top 40 articles from the past 6 months